Exercise Training and Metabolic Flexibility in Prediabetes
NCT ID: NCT04051229
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2019-10-29
2022-08-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Dose-Response Effects in Prediabetes
NCT00962962
Effect of Exercise on Insulin Resistance
NCT01941277
Mechanisms of Fatigability With Diabetes
NCT04442451
The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients
NCT00472342
Resistance Training for the Improvement of Glycemic Control in Prediabetes
NCT06697756
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal of this proposal is to study the impact of a 6-week moderate intensity walking training program on exercise induced lipid metabolic flexibility in older adults with prediabetes. Study Investigators will seek to determine if exercise induced lipid oxidation following a high fat diet is increased in trained individuals relative to their baseline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise Training Group
All 20 participants will be assigned to this arm. These individuals will participate in 6 weeks of a moderate supervised aerobic exercise training program.
6-week exercise training program
Participants will walk at 50% Heart Rate Reserve (HRR) 3 to 5 days per week for 6 weeks at the Department of Health and Exercise Science Clinical Research Center under the supervision of study staff.
Standardized isoenergetic high fat diet
Prior to the submaximal exercise testing visits, all participants will be provided with 3 days of a standardized isoenergetic high fat diet (20% of kcals from carbohydrate, 65% fat; 15% protein) to promote lipid oxidation. The meals will be prepared and provided by the Clinical Research Unit of Wake Forest Baptist Health. Participants will pick up 3 days' worth of food and snacks 4 days prior the testing visit. For the 3 days leading up to the visit, participants will eat the provided foods and complete a compliance assessment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
6-week exercise training program
Participants will walk at 50% Heart Rate Reserve (HRR) 3 to 5 days per week for 6 weeks at the Department of Health and Exercise Science Clinical Research Center under the supervision of study staff.
Standardized isoenergetic high fat diet
Prior to the submaximal exercise testing visits, all participants will be provided with 3 days of a standardized isoenergetic high fat diet (20% of kcals from carbohydrate, 65% fat; 15% protein) to promote lipid oxidation. The meals will be prepared and provided by the Clinical Research Unit of Wake Forest Baptist Health. Participants will pick up 3 days' worth of food and snacks 4 days prior the testing visit. For the 3 days leading up to the visit, participants will eat the provided foods and complete a compliance assessment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sedentary prior to the start of the training program (self-reported: less than 30 minutes of exercise for no more than 1 day a week)
* Prediabetes (measured at first screening: HbA1c = 5.7-6.5%)
* Must be able to pick-up and consume study provided foods
* Willingness to provide informed consent and participate in the intervention
* Must obtain transportation to visits and intervention training sessions
* No contraindications for involvement in a moderate exercise training program or exercise testing procedures by self-report
Exclusion Criteria
* Current or recent (\<12 months) treatment for cancer
* Body Mass Index \<18.5 or \>/30.0 kg/m2
* Tobacco users
* Febrile or chronic infection within study period
* Aversion to testing procedures
* Hypertension, hyperthyroidism, hypothyroidism
* Unwilling to abstain from ingesting caffeine during study testing periods
* Unwilling to withhold medications that affect metabolic rate during testing periods
* Physically active (\>30 minutes per day on more than 1 day per week)
* ECGs that indicate cardiac injury or contraindications to treadmill testing
* Allergic or intolerant to any study-provided foods
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Miller, PhD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest Department of Health and Exercise Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Health and Exercise Science Clinical Research Center
Winston-Salem, North Carolina, United States
Wake Forest Baptist Medical Center Clinical Research Unit
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10000441
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB00058517
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.